Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GAO on HHS

Executive Summary

Government Accounting Office report on HHS says FDA's "capability to approve new drugs and monitor the safety of drugs on the market has been hampered by inadequate information systems." The report cites outdated information systems as a problem for most HHS agencies. The report also cites the need for a process to coordinate the development of programs of the different HHS departments, noting that programs such as FDA's "Action Plan" are developed "without a common understanding of HHS' future"....

Latest Headlines
See All
UsernamePublicRestriction

Register

PS014684

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel